VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients
Open Access
- 31 January 2013
- journal article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 32 (1), 120-128
- https://doi.org/10.1016/j.healun.2012.09.030
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Value of the First Post-Transplant Biopsy for Predicting Long-Term Cardiac Allograft Vasculopathy (CAV) and Graft Failure in Heart Transplant PatientsPLOS ONE, 2012
- Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following TransplantationFrontiers in Immunology, 2012
- Immunotherapy for B-Cell Lymphoma: Current Status and Prospective AdvancesFrontiers in Immunology, 2012
- Lymphangiogenesis Is Required for Pancreatic Islet Inflammation and DiabetesPLOS ONE, 2011
- Urinary Chemokines CXCL9 and CXCL10 Are Noninvasive Markers of Renal Allograft Rejection and BK Viral InfectionAmerican Journal of Transplantation, 2011
- Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivoBlood, 2010
- Donor Age Is Associated With Chronic Allograft Vasculopathy After Adult Heart Transplantation: Implications for Donor AllocationThe Annals of Thoracic Surgery, 2010
- Platelets actively sequester angiogenesis regulatorsBlood, 2009
- Endothelial Cells in Allograft RejectionTransplantation, 2008
- Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression ProfilingAmerican Journal of Transplantation, 2005